Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Naamah L Zitomersky"'
Autor:
Naamah L Zitomersky, Benjamin J Atkinson, Sarah W Franklin, Paul D Mitchell, Scott B Snapper, Laurie E Comstock, Athos Bousvaros
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e63686 (2013)
There is extensive evidence implicating the intestinal microbiota in inflammatory bowel disease [IBD], but no microbial agent has been identified as a sole causative agent. Bacteroidales are numerically dominant intestinal organisms that associate wi
Externí odkaz:
https://doaj.org/article/dd7c33b2592d446091bd9be0c53ad9f8
Autor:
Liza Konnikova, Jessica Toothaker, Rima Fawaz, Jared Silverstein, Randi G. Pleskow, Michael Field, Susanna Huh, Beth-Ann Norton, Sabina Sabharwal, Amit S. Grover, Laurie N. Fishman, Peng Liu, Silvana Bonilla, Rachel W. Winter, Jose Ordovas-Montanes, Alex K. Shalek, Punyanganie S. de Silva, Anne A. Wolf, Jodie Ouahed, Bruce H. Horwitz, Sonia Arora Ballal, Victor L. Fox, Frederick L. Makrauer, Marko Vukovic, Sonia Friedman, Leslie S. Kean, Scott B. Snapper, Sarah Wall, Menno Verhave, Leslie M. Higuchi, Athos Bousvaros, Munir Mobassaleh, Stacy A. Kahn, Collin C. McCourt, Jessica R. Allegretti, Naamah L. Zitomersky, Joshua R. Korzenik, Dennis J. Spencer, Alejandro Flores, Vanessa Mitsialis, Jeff Goldsmith, Lori A. Zimmerman, George C. Tseng, Matthew J. Hamilton, Paul A. Rufo, Brian P. Regan, Tamar Parmet, Christine K. Lee
Publikováno v:
Gastroenterology
Background & Aims Studies are needed to determine the mechanisms of mucosal dysregulation in patients with inflammatory bowel diseases (IBDs) and differences in inflammatory responses of patients with ulcerative colitis (UC) vs Crohn’s disease (CD)
Autor:
Scott B. Snapper, Athos Bousvaros, Snehal Naik, Enju Liu, Lisa Yue Chi, Sophia Tollefson, Naamah L. Zitomersky, Julia Bender-Stern
Publikováno v:
Inflammatory bowel diseases. 24(6)
Goal The aim of this study was to evaluate the effect of combination therapy with methotrexate or 6-mercaptopurine on infliximab levels (IFXL) and antibodies to infliximab (ATI). Background Infliximab (IFX) is a highly effective therapy for inflammat
Autor:
Maureen Gallant, Stephen M. Cifuni, Scott B. Snapper, Melanie Demers, Kimberly Martinod, Denisa D. Wagner, Naamah L. Zitomersky, Amlan Biswas
Publikováno v:
TH Open, Vol 01, Iss 01, Pp e11-e23 (2017)
Background Inflammatory bowel disease (IBD) affects 1.6 million people in the United States. IBD is associated with an increased risk of thrombosis, which rises with disease activity. The pathogenesis of IBD and its increased thrombotic risk is not c
Publikováno v:
Pediatrics. 135:e1060-e1063
Cyclic vomiting syndrome (CVS) is a well-established cause of recurrent vomiting in the pediatric population. Severe vomiting with chronic cannabis use, known as cannabinoid hyperemesis syndrome, has recently been more widely recognized as an etiolog
Autor:
Anne E. Levine, Athos Bousvaros, Cameron C. Trenor, Patricia Sobczyk, Lisa Y. Chi, Naamah L. Zitomersky
Publikováno v:
Inflammatory Bowel Diseases. 25:S35-S35
Autor:
Naamah L. Zitomersky, Anne E. Levine, Cameron C. Trenor, Benjamin J. Atkinson, Jenifer R. Lightdale, Menno Verhave, Athos Bousvaros, Kathy M. Harney
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 57:343-347
Objectives:Pediatric inpatients with inflammatory bowel disease (IBD) are rarely considered for thromboprophylaxis because of concerns about safety and underappreciation of thrombotic risk. We characterized thromboembolism (TE) in children and young
Publikováno v:
Infection and Immunity. 79:2012-2020
Bacteroidales species are the most abundant Gram-negative bacteria of the human intestinal microbiota. These bacteria evolved to synthesize numerous capsular polysaccharides (PS) that are subject to phase variation. In Bacteroides fragilis , PS synth
Publikováno v:
Inflammatory Bowel Diseases. 17:458-470
Thrombotic complications in patients with inflammatory bowel disease (IBD) are common and require improved awareness and prevention. In this review the interface between IBD and thrombosis is discussed, with emphasis on risk assessment and data to ai
Autor:
Sophia Tollefson, Julia Bender Stern, Lisa Chi, Naamah L. Zitomersky, Scott B. Snapper, Athos Bousvaros, Enju Liu, Paul A. Rufo, Snehal Naik
Publikováno v:
Gastroenterology. 154:S-60